Showing results (201-210 of 326) with videos related to
Sort By:
Pageof 33
Oncoimmunology|December 8, 2018
Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradationIsabell Adam, Dyah L Dewi, Joram Mooiweer, et al.Cell Stem Cell|February 12, 2025
Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapyTianping Peng, Xiujian Ma, Wei Hua, et al.Neuro-Oncology|June 3, 2026
Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all AgesAbigail K Suwala, Dennis Friedel, Felix E Hinz, et al.Frontiers in Immunology|November 24, 2017
Iron Induces Anti-tumor Activity in Tumor-Associated MacrophagesMilene Costa da Silva, Michael O Breckwoldt, Francesca Vinchi, et al.European Journal of Cancer (Oxford, England : 1990)|November 15, 2022
Thrombocytopenia limits the feasibility of salvage lomustine chemotherapy in recurrent glioblastoma: a secondary analysis of EORTC 26101Emilie Le Rhun, Felix Boakye Oppong, Martin van den Bent, et al.Cancer Research|November 3, 2004
SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivoMartin Uhl, Steffen Aulwurm, Jörg Wischhusen, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 12, 2020
Large-scale characterization of the microvascular geometry in development and disease by tissue clearing and quantitative ultramicroscopyArtur Hahn, Julia Bode, Allen Alexander, et al.Oncotarget|July 23, 2016
Slowing down glioblastoma progression in mice by running or the anti-malarial drug dihydroartemisinin? Induction of oxidative stress in murine glioblastoma therapyDieter Lemke, Hans-Werner Pledl, Markus Zorn, et al.American Journal of Respiratory and Critical Care Medicine|April 5, 2018
Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung CancerYoshikane Yamauchi, Seyer Safi, Carolin Blattner, et al.Neuro-Oncology Practice|March 20, 2025
Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 studyLinda Dirven, Abigirl Machingura, Martin J van den Bent, et al.Pageof 33